Valenti R - Search Results

1

Tumour-released exosomes and their implications in cancer immunity.

Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, Rivoltini L. Iero M, et al. Among authors: valenti r. Cell Death Differ. 2008 Jan;15(1):80-8. doi: 10.1038/sj.cdd.4402237. Epub 2007 Oct 12. Cell Death Differ. 2008. PMID: 17932500 Review.

2

Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Filipazzi P, Valenti R, Huber V, Pilla L, Canese P, Iero M, Castelli C, Mariani L, Parmiani G, Rivoltini L. Filipazzi P, et al. Among authors: valenti r. J Clin Oncol. 2007 Jun 20;25(18):2546-53. doi: 10.1200/JCO.2006.08.5829. J Clin Oncol. 2007. PMID: 17577033

3

Tumor-released microvesicles as vehicles of immunosuppression.

Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Valenti R, et al. Cancer Res. 2007 Apr 1;67(7):2912-5. doi: 10.1158/0008-5472.CAN-07-0520. Cancer Res. 2007. PMID: 17409393 Review.

4

Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.

Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, Corbelli A, Fais S, Parmiani G, Rivoltini L. Valenti R, et al. Cancer Res. 2006 Sep 15;66(18):9290-8. doi: 10.1158/0008-5472.CAN-06-1819. Cancer Res. 2006. PMID: 16982774

5

Vaccination: role in metastatic melanoma.

Pilla L, Valenti R, Marrari A, Patuzzo R, Santinami M, Parmiani G, Rivoltini L. Pilla L, et al. Among authors: valenti r. Expert Rev Anticancer Ther. 2006 Aug;6(8):1305-18. doi: 10.1586/14737140.6.8.1305. Expert Rev Anticancer Ther. 2006. PMID: 16925496 Review.

6

Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?

Rivoltini L, Canese P, Huber V, Iero M, Pilla L, Valenti R, Fais S, Lozupone F, Casati C, Castelli C, Parmiani G. Rivoltini L, et al. Among authors: valenti r. Expert Opin Biol Ther. 2005 Apr;5(4):463-76. doi: 10.1517/14712598.5.4.463. Expert Opin Biol Ther. 2005. PMID: 15934826 Review.

7

Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.

Tosi D, Valenti R, Cova A, Sovena G, Huber V, Pilla L, Arienti F, Belardelli F, Parmiani G, Rivoltini L. Tosi D, et al. Among authors: valenti r. J Immunol. 2004 May 1;172(9):5363-70. doi: 10.4049/jimmunol.172.9.5363. J Immunol. 2004. PMID: 15100276

8

Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape.

Huber V, Fais S, Iero M, Lugini L, Canese P, Squarcina P, Zaccheddu A, Colone M, Arancia G, Gentile M, Seregni E, Valenti R, Ballabio G, Belli F, Leo E, Parmiani G, Rivoltini L. Huber V, et al. Among authors: valenti r. Gastroenterology. 2005 Jun;128(7):1796-804. doi: 10.1053/j.gastro.2005.03.045. Gastroenterology. 2005. PMID: 15940614

9

Iopiperidol: nonionic iodinated contrast medium with promising anticoagulant and antiplatelet properties.

Valenti R, Motta A, Merlini S, Morisetti A, Tirone P. Valenti R, et al. Acad Radiol. 1999 Jul;6(7):426-32. doi: 10.1016/s1076-6332(99)80193-7. Acad Radiol. 1999. PMID: 10410168

10

General pharmacology in experimental animals of gadobenate dimeglumine (MultiHance), a new magnetic resonance imaging contrast agent.

Tirone P, Castano M, Cipolla P, Frigeni V, La Noce A, Luzzani F, Valenti R, de Haën C. Tirone P, et al. Among authors: valenti r. J Comput Assist Tomogr. 1999 Nov;23 Suppl 1:S195-206. doi: 10.1097/00004728-199911001-00024. J Comput Assist Tomogr. 1999. PMID: 10608415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results